Literature DB >> 9716611

Lymphocyte subset analysis and glycosylphosphatidylinositol phenotype in patients with paroxysmal nocturnal hemoglobinuria.

S J Richards1, D R Norfolk, D M Swirsky, P Hillmen.   

Abstract

Using multicolor flow-cytometry we have examined 19 patients with paroxysmal nocturnal hemoglobinuria (PNH) (18 with active disease and 1 spontaneous remitter) to determine absolute numbers of lymphocyte subsets and the proportion of glycosylphosphatidylinositol (GPI)-deficient clones amongst these subpopulations. Lymphocyte subsets were abnormal in all patients; the most frequent findings were low absolute numbers of natural killer (NK) cells (median, 0.08 x 10(9)/L; normal range, 0.2 to 0.4 x 10(9)/L) and low absolute numbers of B cells (median, 0.05 x 10(9)/L; normal range, 0.06 to 0.65 x 10(9)/L). GPI-deficient B, T, and NK cells were identified in 88%, 84%, and 89% of patients, respectively. The proportion of GPI-deficient cells within individual lymphoid lineages was highly variable, though in most patients the percentage of GPI-deficient NK cells was considerably higher than B or T cells. These observations can be explained when mechanisms of normal lymphopoiesis are considered. Despite these quantitative and qualitative abnormalities, no patients suffered an excessive number or severity of infections. The detection of PNH clones amongst all lymphocyte lineages may provide important information regarding the natural history of the disease and additional insights into kinetics of adult lymphopoiesis. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716611

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs.

Authors:  Marcus A F Corat; Heinrich Schlums; Chuanfeng Wu; Jakob Theorell; Diego A Espinoza; Stephanie E Sellers; Danielle M Townsley; Neal S Young; Yenan T Bryceson; Cynthia E Dunbar; Thomas Winkler
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

Review 2.  Paroxysmal nocturnal haemoglobinuria: nature's gene therapy?

Authors:  R J Johnson; P Hillmen
Journal:  Mol Pathol       Date:  2002-06

Review 3.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

4.  Combination of lymphocyte number and function in evaluating host immunity.

Authors:  Ying Luo; Yalong Xie; Weijie Zhang; Qun Lin; Guoxing Tang; Shiji Wu; Min Huang; Botao Yin; Jin Huang; Wei Wei; Jing Yu; Hongyan Hou; Liyan Mao; Weiyong Liu; Feng Wang; Ziyong Sun
Journal:  Aging (Albany NY)       Date:  2019-12-20       Impact factor: 5.682

5.  Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.

Authors:  Hubert Schrezenmeier; Alexander Röth; David J Araten; Yuzuru Kanakura; Loree Larratt; Jamile M Shammo; Amanda Wilson; Gilda Shayan; Jaroslaw P Maciejewski
Journal:  Ann Hematol       Date:  2020-05-10       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.